Arcus Biosciences (RCUS) Interest & Investment Income (2018 - 2026)
Arcus Biosciences (RCUS) posted quarterly Interest & Investment Income of $9.0 million for Q1 2026, down 18.18% year-over-year from $11.0 million in Q1 2025, and down 10.0% quarter-over-quarter from $10.0 million in Q4 2025.
Arcus Biosciences (RCUS) Interest & Investment Income (2018 - 2026) Analysis & Trends
Arcus Biosciences' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 18.18% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $39.0 million (down 22.0% YoY), while the FY2025 annual figure was $41.0 million, down 21.15% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $9.0 million, down from $10.0 million in the prior quarter.
- The five-year high for Interest & Investment Income was $14.0 million in Q3 2024, with the low at $582000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $10.0 million (2025), against an average of $9.4 million.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income surged 3005.59% in 2022, then slipped 28.57% in 2025.
- Arcus Biosciences' Interest & Investment Income stood at $8.0 million in 2022, then jumped by 37.5% to $11.0 million in 2023, then increased by 9.09% to $12.0 million in 2024, then fell by 16.67% to $10.0 million in 2025, then declined by 10.0% to $9.0 million in 2026.
- Business Quant data shows RCUS's Interest & Investment Income at $9.0 million in Q1 2026, $10.0 million in Q4 2025, and $10.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Arcus Biosciences | 3.74 Bn | 3.04 Bn | - | 8.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.00 Mn |
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | 10.00 Mn |
| Sep 30, 2025 | 10.00 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 11.00 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Sep 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | 13.00 Mn |
| Mar 31, 2024 | 13.00 Mn |
| Dec 31, 2023 | 11.00 Mn |
| Sep 30, 2023 | 12.00 Mn |
| Jun 30, 2023 | 9.00 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Dec 31, 2022 | 8.00 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | 582,000.00 |
| Dec 31, 2021 | 519,000.00 |
| Sep 30, 2021 | 161,000.00 |